Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia

Por um escritor misterioso

Descrição

Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Children, Free Full-Text
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
PDF] Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Therapeutic implications of menin inhibition in acute leukemias
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo - ScienceDirect
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1, Cancer Cell International
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Challenges and opportunities in targeting the menin-MLL interaction.
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as Therapeutic Agents for Acute Leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Current status and future perspectives in targeted therapy of NPM1-mutated AML
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors as  Therapeutic Agents for Acute Leukemia
Cancers, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)